Drugs

, Volume 78, Issue 5, pp 609–609 | Cite as

Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors

Correction
  • 588 Downloads

1 Correction to: Drugs  https://doi.org/10.1007/s40265-018-0874-x

Figure 1

The dose (mg/day) for Clonazepam which reads:

80–240

Should read:

0.25–4

Figure 1

The dose (mg/day) for Gingko biloba which reads:

0.25–4**

Should read:

80–400

Figure 1

The legend, which reads

Management of tardive dyskinesia. DRBA dopamine receptor-blocking agent, GPi globus pallidus interna, TD tardive dyskinesia, VMAT2 vesicular monoamine transporter 2. *Similar side effects but may be better tolerated than tetrabenazine. **240 mg/day used in randomized controlled trial

Should read:

Management of tardive dyskinesia. DRBA dopamine receptor-blocking agent, GPi globus pallidus interna, TD tardive dyskinesia. *Deutetrabenazine and valbenazine may be better tolerated than tetrabenazine

The original article has been corrected.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Parkinson’s Disease Center and Movement Disorders Clinic, Department of NeurologyBaylor College of MedicineHoustonUSA

Personalised recommendations